Vivos Therapeutics, Inc. (VVOS) NASDAQ

0.68

-0.0068(-0.99%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap20.86M
Enterprise Value32.33M
P/E Ratio-0.4
PEG Ratio0.02
Price/Sales Ratio0.2
Price/Book Ratio-8.72
Enterprise/Revenue0.72
Enterprise/EBITDA-0.67

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-1.28
Operating Margin-1.15

Management Effectiveness

Return On Assets-1
Return On Equity-22.39

Income Statement

Revenue17.44M
Revenue/Share1.34
Gross Profit10.54M
EBITDA-18.59M
Net Income-21.23M
Diluted EPS-2.06

Balance Sheet

Total Cash2.11M
Total Cash/Share0.14
Total Debt12.27M
Total Debt/Equity-10.78
Current Ratio0.27
Book Value Per Share-0.09

Price History

52-Week Change-71.74
52-Week High7.95
52-Week Low0.55
Moving Average 50 Days0.92
Moving Average 200 Days2.09

Statistics

Average Volume226,273
Shares Outstanding5.89M
% Held by Institutions16.62

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateOctober 27, 2023